← FDA Drug Approvals (Drugs@FDA)

KLAYESTA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EPIC PHARMA LLC · Approved 2018-04-30

Drug application

FDA Application #

ANDA210532

Application type

Abbreviated New Drug Application (Generic)

Brand name

KLAYESTA

Generic name

NYSTATIN TOPICAL POWDER

Active ingredients

NYSTATIN

Dosage form

POWDER

Route

TOPICAL

Marketing status

Prescription

Sponsor

EPIC PHARMA LLC

Manufacturer

Epic Pharma, LLC

First approval

2018-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown